Novanta announces $300M private placement

What's the deal? NovantaDealroom has a profile for this one. Try Dealroom → Inc., a Boston-based photonics and precision technology company, has entered into a securities purchase agreement to sell shares privately to institutional and accredited investors, raising roughly $300M in gross proceeds before fees and expenses.

The company agreed to sell 2,142,857 common shares at $140.00 per share. The placement is expected to close on or around June 11, 2026.

Why now? The deal was announced on June 9, 2026, with a rapid two-day turnaround to closing — a pace typical of private placements, which bypass the lengthy regulatory process of a public offering. By going this route, Novanta can access capital quickly without filing a full registration statement upfront.

What could go wrong? Private placements dilute existing shareholders. At over two million new shares, current investors will see their stakes shrink. The shares were also sold at a fixed price of $140.00, meaning any discount to market price would amplify dilution concerns.

Because the shares haven't been registered under the Securities Act, buyers face restrictions on resale — limiting liquidity until a registration statement is filed. Novanta has entered into a registration rights agreement giving investors a path to eventual resale, but the timeline remains unclear.

The signal: Novanta's $300M raise is notable for a mature photonics and precision technology company that already trades publicly — suggesting the capital is earmarked for something specific, whether a sizable acquisition or a major expansion push. The speed and structure of the placement point to institutional confidence in the company's trajectory, even as the undisclosed use of proceeds leaves shareholders guessing about what comes next.

Read more: stocktitan.net